Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:serotonin_receptor_antagonist |
| gptkbp:alternativeName |
Zatosetron
|
| gptkbp:CASNumber |
117052-90-9
|
| gptkbp:developedBy |
treatment of nausea and vomiting
|
| gptkbp:drugClass |
gptkb:antiemetic
|
| gptkbp:hasMolecularFormula |
C17H18Cl2N2O2
|
| gptkbp:hasSMILES |
CN1CC2=C(C1)C(=O)N(C(C2)C3=CC(=CC(=C3)Cl)Cl)C
|
| gptkbp:hasUNII |
6Q1K7K2E1F
|
| gptkbp:IUPACName |
(3aS,4S,7aR)-4-(3,5-dichlorophenyl)-1,2,3,3a,4,7-hexahydro-7a-methyl-1,4-benzoxazepin-2-one
|
| gptkbp:PubChem_CID |
60713
CHEMBL2105892 |
| gptkbp:targets_receptor |
gptkb:5-HT3_receptor
|
| gptkbp:bfsParent |
gptkb:Letrozole
gptkb:letrozole |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
CGS 20267
|